Opinion|Videos|July 24, 2024
Financial Considerations Influencing Treatment Strategies in PNH Treatment Pathway
The panelists provide their final thoughts, highlighting financial considerations in PNH treatment.
Advertisement
Episodes in this series
Video content above is prompted by the following question:
- How do financial considerations influence your treatment decision-making process?
Advertisement
Related to this article
This moves the noncovalent BTK inhibitor into the first-line setting for certain adults with chronic lymphocytic leukemia or small lymphocytic lymphoma.
The article explores the use of dose-intensive IV iron replacement to achieve long-term hemoglobin stability in patients with moderate to severe HHT-related bleeding. The approach recognizes what the author calls "the relentless and recurrent nature of HHT-associated bleeding," and may help patients achieve better quality of life.
CAR T-cell therapy must be treated as a complete "vein-to-vein" episode, with community practices needing to take control of cases for a period of time.
Aligning financial incentives with patient-centered care is becoming an increasingly complex path to navigate within oncology.
Advertisement
Advertisement
Trending on AJMC
1
Systemic Sclerosis Linked to Dramatic Rise in Lung Cancer Risk
2
FDA Approves First Heart Valve to Keep Pace With Children's Growth
3
Psoriasis Is Much Rarer in Indigenous Groups Worldwide
4
Traditional Medicare OOP Cap Could Lower Costs, Raise Federal Spending
5